9.625
3.83%
0.355
시간 외 거래:
9.49
-0.135
-1.40%
Applied Therapeutics Inc 주식(APLT)의 최신 뉴스
When (APLT) Moves Investors should Listen - Stock Traders Daily
Applied Therapeutics, Inc. (NASDAQ:APLT) Sees Large Drop in Short Interest - MarketBeat
Perceptive Advisors LLC Expands Stake in Applied Therapeutics Inc - GuruFocus.com
Alyeska Investment Group, L.P. Increases Stake in Applied Therap - GuruFocus.com
Janus Henderson Group PLC's Strategic Investment in Applied Ther - GuruFocus.com
Vestal Point Capital's Strategic Reduction in Applied Therapeuti - GuruFocus.com
Applied Therapeutics (NASDAQ:APLT) Sets New 1-Year HighWhat's Next? - MarketBeat
Analysts Set Applied Therapeutics, Inc. (NASDAQ:APLT) PT at $12.50 - Defense World
Applied Therapeutics, Inc. (NASDAQ:APLT) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
How To Trade (APLT) - Stock Traders Daily
Applied Therapeutics Inc (APLT) Quarterly 10-Q Report - Quartzy
APLTApplied Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan
Applied Therapeutics Inc (APLT) Is On The Launchpad, Waiting For Long-Term Buyers. - Stocks Register
Applied Therapeutics Reports Third Quarter 2024 Financial Results - The Manila Times
APLT (Applied Therapeutics) Cash From Other Investing Activities : $0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com
Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference - GlobeNewswire
Applied Therapeutics stock hits 52-week high at $9.41 By Investing.com - Investing.com Canada
Applied Therapeutics (NASDAQ:APLT) Reaches New 1-Year HighHere's What Happened - MarketBeat
Applied Therapeutics stock hits 52-week high at $9.41 - Investing.com
US FDA’s November Goal Dates Cannot Elevate 2024’s Novel Approvals To 2023 Levels - Citeline News & Insights
Seven PDUFA dates on FDA’s November calendar - BioCentury
Biotech Stocks Facing FDA Decision In November 2024 - RTTNews
Applied Therapeutics (APLT) Upgraded to Buy: Here's What You Should Know - MSN
ImmunityBio (IBRX) Soars 26.4%: Is Further Upside Left in the Stock? - MSN
Is Applied Therapeutics (APLT) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Trigg Minerals Announces Key AGM Resolutions - MSN
Trading (APLT) With Integrated Risk Controls - Stock Traders Daily
Applied Therapeutics, Inc. (NASDAQ:APLT) Short Interest Update - MarketBeat
OncoSil Medical Plans Major Stock Issuance - MSN
Applied Therapeutics (NASDAQ:APLT) versus Ironwood Pharmaceuticals (NASDAQ:IRWD) Head-To-Head Analysis - Defense World
Hennion & Walsh Asset Management Inc. Has $2.26 Million Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat
Applied Therapeutics (NASDAQ:APLT) Shares Down 4.9%Here's What Happened - MarketBeat
William Blair Issues Pessimistic Outlook for APLT Earnings - Defense World
Q2 EPS Estimate for Applied Therapeutics Cut by Analyst - MarketBeat
Sharps Technology files to sell 259,092 shares of common stock for holders - MSN
Ardmore Shipping leads tanker stocks lower as Stifel downgrades, seeing softer rates - MSN
Invesco BulletShares 2024 High Yield Corporate Bond ETF declares monthly distribution of $0.1100 - MSN
Is the Options Market Predicting a Spike in American Healthcare REIT, Inc. (AHR) Stock? - MSN
Waste Connections Q3 2024 Earnings Preview - MSN
APLT Stock Soars 69% on Positive Update on Galactosemia Drug NDA - MSN
Viking Therapeutics Stock: Buy or Sell Before Q3 Earnings? - MSN
Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views? - MSN
Analysts Set Applied Therapeutics, Inc. (NASDAQ:APLT) Price Target at $12.50 - Defense World
Applied Therapeutics (NASDAQ:APLT) Trading Down 2.2%Here's What Happened - MarketBeat
There is no doubt that Applied Therapeutics Inc (APLT) ticks all the boxes. - SETE News
Applied Therapeutics Inc’s Market Journey: Closing Strong at 9.14, Up 2.81 - The Dwinnex
Varonis Systems Inc [VRNS] Investment Appeal on the Rise - Knox Daily
Applied Therapeutics Inc (APLT) gets rating Initiated from William Blair - Knox Daily
Wedbush’s latest rating for SYRE stock - Knox Daily
Omega Healthcare Investors, Inc.’s latest rating changes from various analysts - Knox Daily
Analysts review Liberty Energy Inc’s rating - Knox Daily
Applied Therapeutics (NASDAQ:APLT) Shares Up 6.4%Should You Buy? - MarketBeat
Applied Therapeutics, Inc. (NASDAQ:APLT) Short Interest Up 14.2% in September - MarketBeat
APLT overperforms with a 4.51 increase in share price - US Post News
Brokerages Set Applied Therapeutics, Inc. (NASDAQ:APLT) Target Price at $12.50 - MarketBeat
23,476 Shares in Applied Therapeutics, Inc. (NASDAQ:APLT) Acquired by Algert Global LLC - Defense World
자본화:
|
볼륨(24시간):